Official UK visa sponsor profile for BenevolentAI Ltd in London, including current register status, route details, and public company data.
BenevolentAI Ltd is a leading artificial intelligence (AI) company focused on transforming the biopharma industry through advanced machine learning. Founded in 2015, the company operates as a limited liability company (Ltd) with a registered address at 4-8 Maple Street, London, W1T 5HD. BenevolentAI’s core business centers around utilizing sophisticated AI algorithms to accelerate the drug discovery process. The company’s primary service is applying cutting-edge AI technologies to identify novel drug targets, predict drug efficacy, and optimize clinical trial design. BenevolentAI’s expertise spans various stages of drug development, including target identification, lead optimization, and preclinical research. As a leader in this field, BenevolentAI has established a significant international presence, collaborating with pharmaceutical companies globally. The company’s size is considered substantial, and its strategic focus is firmly on biopharma drug discovery. BenevolentAI’s international operations are supported by a strong hiring indicator, reflecting its commitment to expanding its team and capabilities. BenevolentAI’s SIC codes include -74909: Other professional, scientific and technical activities n.e.c, and the company is classified as a “Worker” visa holder, rating A.
Official UK visa sponsor profile for BenevolentAI Ltd in London, including current register status, route details, and public company data.
BenevolentAI Ltd is a leading artificial intelligence (AI) company focused on transforming the biopharma industry through advanced machine learning. Founded in 2015, the company operates as a limited liability company (Ltd) with a registered address at 4-8 Maple Street, London, W1T 5HD. BenevolentAI’s core business centers around utilizing sophisticated AI algorithms to accelerate the drug discovery process. The company’s primary service is applying cutting-edge AI technologies to identify novel drug targets, predict drug efficacy, and optimize clinical trial design. BenevolentAI’s expertise spans various stages of drug development, including target identification, lead optimization, and preclinical research. As a leader in this field, BenevolentAI has established a significant international presence, collaborating with pharmaceutical companies globally. The company’s size is considered substantial, and its strategic focus is firmly on biopharma drug discovery. BenevolentAI’s international operations are supported by a strong hiring indicator, reflecting its commitment to expanding its team and capabilities. BenevolentAI’s SIC codes include -74909: Other professional, scientific and technical activities n.e.c, and the company is classified as a “Worker” visa holder, rating A.
Yes, BenevolentAI Ltd is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
BenevolentAI Ltd is classified under: Other professional, scientific and technical activities n.e.c..
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, BenevolentAI Ltd is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
BenevolentAI Ltd is classified under: Other professional, scientific and technical activities n.e.c..
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.